Hi Joe, I agree with you that holders like him are concerning. I think Vifor's performance will be known by august next year tbh.
On another topic, you responded to my posts about how CSL is so overpriced before. I did an alternative calculation of CSL's intrinsic value (and other stocks), without slapping a terminal value which I felt totally defeats the purpose of arriving at a P/E in the first place, 25 year time frame. CSL, while still definitely overpriced, turned out to be not as overpriced as I thought, while the low p/e value stocks turned out to be not as cheap as I thought.
If it makes a triple bottom at $240s, according to my demands for investment returns, I will be loading up big.
- Forums
- ASX - By Stock
- CSL
- Ann: Trading Halt
Ann: Trading Halt, page-136
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$285.54 |
Change
-1.120(0.39%) |
Mkt cap ! $138.2B |
Open | High | Low | Value | Volume |
$285.50 | $285.86 | $282.18 | $110.7M | 388.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 368 | $285.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$285.54 | 425 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 251 | 285.310 |
1 | 123 | 285.280 |
1 | 138 | 285.200 |
1 | 80 | 285.100 |
1 | 985 | 285.020 |
Price($) | Vol. | No. |
---|---|---|
285.540 | 425 | 1 |
285.600 | 810 | 1 |
285.670 | 916 | 1 |
285.760 | 842 | 1 |
285.770 | 303 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online